Autoantibodies against contactin-1 were shown to be present in a subset of patients suffering from chronic inflammatory demyelinating polyneuropathy (CIDP) (Querol et al., 2013), suggesting that contactin-1 is involved in neuromyopathies. Here, CNTN1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.